![David Wambeke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wambeke
No más puestos en curso
Fortuna: 8 M $ al 31/07/2026
Perfil
David John Wambeke worked at Craig-Hallum Capital Group LLC from 2007 to 2023, including the role of Partner & Managing Director in 2023.
From 2023 to 2025, worked at DiaMedica Therapeutics, Inc. as Chief Business Officer.
Attended the University of Minnesota for undergraduate studies.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/06/2025 | 527.114 ( 0,98 % ) | 3 M $ | 31/07/2026 | |
| 01/06/2024 | 527.114 ( -.--% ) | 3 M $ | 31/07/2026 | |
INEO Tech Corp.
 INEO Tech Corp. Advertising/Marketing ServicesCommercial Services Operates location-based advertising, analytics and theft detection platform for retailers 19,93 % | 18/06/2026 | 10.374.430 ( 19,93 % ) | 757 333 $ | 31/07/2026 |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops thin film electrode technology for epileptic patients 1,92 % | 01/03/2026 | 166.667 ( 1,92 % ) | 281 667 $ | 31/07/2026 |
Antiguos cargos conocidos de David Wambeke.
| Empresas | Cargo | Fin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2025 |
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/03/2023 |
Formación de David Wambeke.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
95
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- David Wambeke
